Vaping and Smoking Project in People With Schizophrenia
Recruiting
N/A
Interventional Study
Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 – 50
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 64 (estimated)
- Sponsor
- State University of New York at Buffalo · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preven…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 6+ months of daily/near-daily nicotine vaping or cigarette smoking
* 200+ ng/mL cotinine on a commercially-available quick screen
* stable antipsychotic medication dose (no changes in past 6 months).
Current Exclusion Criteria:
* intention to quit daily/near-daily vaping/smo…
Contacts